Company Number: 13144723

Analysis Date: 2025-07-29 20:52 UTC

Financial Health Assessment of FAKOLY LTD (Company Number: 13144723)

---

1. Financial Health Score: C

Explanation:
FAKOLY LTD shows signs of financial stability but with warning signals that require attention. While the company maintains positive net assets and working capital, a steady decline in net assets over recent years and low fixed asset base indicate a fragile financial condition. The absence of employees and minimal share capital further underline a micro-entity status with limited operational scale. The company is not in distress but exhibits symptoms that warrant careful management to improve financial resilience.

---

2. Key Vital Signs

Metric	Latest Value (2024)	Interpretation
Net Assets	£4,791	Positive, but a notable decline from £7,378 in 2023 and £10,290 in 2021. Indicates asset erosion.
Fixed Assets	£333	Very low fixed asset base, diminished from previous years. Reflects low investment in long-term assets.
Current Assets	£5,300	Sufficient short-term assets to cover current liabilities, signaling liquidity.
Current Liabilities	£842	Low current liabilities, manageable short-term obligations.
Net Current Assets (Working Capital)	£4,458	Healthy working capital, indicating ability to cover short-term debts comfortably.
Share Capital	£100	Minimal equity capital, typical of micro-entities but limits financial cushion.
Employees	0	No employees reported; may indicate limited or outsourced operations.
Director Advances	£4,567 (repaid)	Director lent money to the company, repaid after year-end—shows reliance on director funding.
Company Status	Active	Not in liquidation or distress, but closely monitored.
Industry	Non-specialised wholesale trade (SIC 46900)	Sector generally requires good liquidity and inventory management.

---

3. Diagnosis: What the Numbers Reveal About Business Health

FAKOLY LTD, as a micro-entity operating in wholesale trade, currently shows a stable but weak financial constitution. The positive net assets and healthy working capital are akin to a patient with a stable heartbeat but low energy levels. The decline in net assets from £10,290 in 2021 to £4,791 in 2024 signals a gradual weakening of the company’s financial "immune system," potentially due to shrinking reserves or losses that are not explicitly reported in profit and loss (P&L) due to micro-entity filing exemptions.

The very low fixed asset base indicates limited investment in property, plant, or equipment, suggesting the company either leases operational assets or operates with minimal physical infrastructure. This could be a strategic choice or a limitation on growth capacity.

The repayment of director advances shortly after year-end shows reliance on director funding, which while helpful, implies an unstable cash flow position that may need external financial support or improved operational cash generation.

The absence of employees suggests a lean or possibly non-operational business model, which may impact future growth and sustainability.

---

4. Recommendations: Specific Actions to Improve Financial Wellness

• Enhance Capital Structure: Consider increasing share capital or attracting external investment to build a stronger equity base, which will provide a buffer against operational risks.

• Improve Asset Management: Evaluate the need for investing in fixed assets or technology to support growth and operational efficiency. Asset investment can improve long-term stability.

• Strengthen Cash Flow Management: Develop a detailed cash flow forecast to reduce reliance on director loans. Explore alternative financing options such as overdrafts or short-term credit facilities.

• Operational Review: Assess the business model given zero employees reported. If outsourcing, ensure contracts are solid and cost-effective. If planning growth, consider hiring or engaging contractors.

• Profit and Loss Tracking: Since micro-entity filings do not require full P&L disclosure, internally maintain detailed profit and loss accounts to identify profit leakage and opportunities for margin improvement.

• Governance and Control: Regularly review director and shareholder structure to ensure clarity and stability. Succession planning and control mechanisms should be documented given recent director changes.

• Compliance and Reporting: Ensure timely filing of accounts and confirmation statements to maintain good standing and avoid penalties.

---